Xiaohong He
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Oncolytic vaccinia virus encoding constitutively active EPAC remodels the tumor microenvironment to enhance therapeutic efficacy with chemotherapy and surgery.
Journal: Journal for immunotherapy of cancer
Published: January 01, 2026
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection.
Journal: Molecular therapy. Methods & clinical development
Published: May 02, 2023
Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development.
Journal: The Journal of biological chemistry
Published: February 08, 2023
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies.
Journal: Nature communications
Published: December 15, 2022
CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Journal: Frontiers in immunology
Published: September 21, 2022
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.
Journal: Frontiers in immunology
Published: August 27, 2022
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy.
Journal: Nature communications
Published: November 11, 2021
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 30, 2021
Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection.
Journal: Journal of visualized experiments : JoVE
Published: June 21, 2021
Modulating SIRT1 activity variously affects thymic lymphoma development in mice.
Journal: Experimental cell research
Published: January 15, 2018
Reversible modulation of SIRT1 activity in a mouse strain.
Journal: PloS one
Published: December 02, 2016
Loss of Sirt1 promotes prostatic intraepithelial neoplasia, reduces mitophagy, and delays PARK2 translocation to mitochondria.
Journal: The American journal of pathology
Published: August 15, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026